Search for: "Illumina, Inc. "
Results 161 - 170
of 170
Sorted by Relevance
|
Sort by Date
9 Jan 2022, 1:45 am
By stark contrast, for example, the EPO only requires that the specification sufficiently discloses a single embodiment falling under the scope of the claim (see also, Regeneron v Kymab, (IPKat) and Illumina v MGI (IPKat)). [read post]
29 Jun 2023, 7:18 am
On June 21, the FTC filed a complaint alleging that: For years, Defendant Amazon.com, Inc. [read post]
19 Jul 2023, 1:30 pm
On July 19, the District Court for the Northern District of California denied the FTC’s bid to enjoin Microsoft’s vertical acquisition of video game publisher Activision. [read post]
28 Jul 2021, 6:00 am
Motorola [2010] EWHC 188 (Pat), and Illumina Inc v Premaitha Health Plc [2017] EWHC 2930 (Pat), and derived the following principles: “(a) the Court’s task is to identify by whom and where, in substance, the method is being used; and (b) it is relevant to take into account that for some steps it simply may not matter where processing power is located. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
24 Jul 2023, 3:59 pm
(We covered this topic in a recent Fifth Circuit amicus brief supporting Illumina.) [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Jun 2019, 9:58 am
U.S. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
1 Feb 2023, 9:05 pm
2022 was a tale of two halves for M&A. [read post]
